EDSA

Edesa Biotech, Inc. - Common Shares (EDSA)

About Edesa Biotech, Inc. - Common Shares (EDSA)

Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquisition, development, and commercialization of drug candidates for medical dermatology and respiratory diseases. Its clinical studies include EB05 for Acute Respiratory Distress Syndrome (ARDS), EB07 for systemic sclerosis (SSc), EB01 for chronic Allergic Contact Dermatitis (ACD), and EB06 for vitiligo. The company was founded by Pardeep Nijhawan on June 12, 2007 and is headquartered in Markham, Canada.

Details

Daily high

$4.24

Daily low

$3.99

Price at open

$4.17

52 Week High

$20.32

52 Week Low

$0.72

Market cap

55.9M

Dividend yield

Volume

41,974

Avg. volume

62,644

P/E ratio

-2.45

Edesa Biotech, Inc. - Common Shares News